Q32 BIO INC QTTB
COM · Common Stock · CUSIP 746964105
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersWaltham, MA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 29.8m as of 2026-08-03, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $12.74. Options: 0 managers hold calls (— notional), 3 hold puts ($3.3m).
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2024 | 39 |
| Q2 2024 | 55 |
| Q3 2024 | 74 |
| Q4 2024 | 93 |
| Q1 2025 | 74 |
| Q2 2025 | 62 |
| Q3 2025 | 53 |
| Q4 2025 | 52 |
| Q1 2026 | 53 |
| Q2 2026 | 71 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2024 | 44 | 16 |
| Q4 2024 | 50 | 30 |
| Q1 2025 | 24 | 44 |
| Q2 2025 | 21 | 41 |
| Q3 2025 | 18 | 34 |
| Q4 2025 | 16 | 28 |
| Q1 2026 | 22 | 17 |
| Q2 2026 | 45 | 21 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2025 | $0 | $0 | — |
| Q4 2025 | $0 | $0 | — |
| Q1 2026 | $0 | $0 | — |
| Q2 2026 | $0 | $3.3m | — |
Biggest buyers
| Boxer Capital Management, LLC | New | +3.1m |
| BVF INC/IL | New | +2.4m |
| RA CAPITAL MANAGEMENT, L.P. | New | +2.3m |
| ORBIMED ADVISORS LLC | Added | +1.9m |
| Point72 Asset Management, L.P. | New | +1.2m |
| Logos Global Management LP | New | +800.0k |
| SummitTX Capital, L.P. | New | +733.8k |
| Atlas Venture Life Science Advisors, LLC | Added | +625.0k |
| Ikarian Capital, LLC | New | +430.0k |
| Woodline Partners LP | New | +286.2k |
Biggest sellers
| Carlyle Group Inc. | Reduced | -1.0m |
| Opaleye Management Inc. | Reduced | -325.2k |
| ARCH Venture Management, LLC | Sold out | -320.5k |
| MACKENZIE FINANCIAL CORP | Sold out | -246.3k |
| Pfizer Inc | Sold out | -101.6k |
| ACORN CAPITAL ADVISORS, LLC | Reduced | -98.9k |
| ADAR1 Capital Management, LLC | Sold out | -35.0k |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | -27.3k |
| Cetera Investment Advisers | Sold out | -20.7k |
| EverSource Wealth Advisors, LLC | Reduced | -4.4k |
Biggest calls
| None |
Biggest puts
| Ikarian Capital, LLC | New | $2.5m200.0k shares |
| BOOTHBAY FUND MANAGEMENT, LLC | New | $781.0k61.3k shares |
| SIMPLEX TRADING, LLC | New | $2.5k200 shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
ORBIMED ADVISORS LLC
13D · may seek influence
-3.5 pts · filed 2026-07-20
Stated purposeThe Reporting Persons from time to time intend to review their investment in the Issuer on the basis of various factors, including the Issuer's business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in general and those for the Issuer's Shares in particular, as well as other developments and other investment opportunities. Based upon such review, the Reporting Persons will take such actions in the future as the Reporting Persons may deem appropriate in light of the circumstances existing from time to time. If the Reporting Persons believe that further investment in the Issuer is attractive, whether because of the market price of Shares or otherwise, they may acquire Shares or other securities of the Issuer either… Full filing |
13.9% |
| Boxer Capital Management, LLC 13G · institution new · filed 2026-07-10 | 13.3% |
| BIOTECHNOLOGY VALUE FUND L P 13G · passive investor new · filed 2026-06-04 | 10.0% |
| RA CAPITAL MANAGEMENT, L.P. 13G · passive investor new · filed 2026-06-04 | 9.8% |
| BANK OF AMERICA CORP /DE/ 13G · institution new · filed 2026-10-28 | 7.4% |
| Frazier Life Sciences Public Fund, L.P. 13G · passive investor new · filed 2026-10-09 | 5.9% |
| Opaleye Management Inc. 13G · passive investor -3.1 pts · filed 2026-07-31 | 5.5% |
Fell to 5% or below in the last year: Point72 Asset Management, L.P. (5.0%, 2026-08-14), Sirenia Capital Management LP (0.0%, 2026-08-14), Carlyle Group Inc. (4.1%, 2026-07-06), Atlas Venture Fund X, L.P. (3.6%, 2026-05-28), PFIZER INC (2.3%, 2026-02-13)
Insider purchases and sales since 1 Apr 2026
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q4 2024 | 0 | — | 0 | — | — |
| Q1 2025 | 0 | — | 0 | — | — |
| Q2 2025 | 0 | — | 0 | — | — |
| Q3 2025 | 0 | — | 3 | $31.9k | — |
| Q4 2025 | 0 | — | 2 | $109.3k | — |
| Q1 2026 | 0 | — | 3 | $75.3k | — |
| Q2 2026 | 2 | $15.0m | 0 | — | — |
| Q3 2026 | 0 | — | 3 | $275.1k | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2026-08-25 | Morrison Jodie Pope CEO, director | Sold | $163.0k9.8k shares |
| 2026-08-25 | Kalowski Lee CFO and President | Sold | $65.8k4.0k shares |
| 2026-08-25 | Violette Shelia M. Chief Scientific Officer | Sold | $46.3k2.8k shares |
| 2026-05-28 | ORBIMED ADVISORS LLC +2 Director · See footnotes | Bought | $15.0m1.9m shares |
| 2026-05-28 | Xu Diyong Director · See footnotes | Bought | $15.0m1.9m shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q2 2026
| Manager | Shares | Change |
|---|---|---|
| ORBIMED ADVISORS LLC 1.00% of their portfolio | 4.1m $52.6m | Added +1.9m |
| Boxer Capital Management, LLC 3.02% of their portfolio | 3.1m $40.1m | New |
| Atlas Venture Life Science Advisors, LLC 3.93% of their portfolio | 2.7m $34.6m | Added +625.0k |
| BVF INC/IL 0.77% of their portfolio | 2.4m $29.9m | New |
| RA CAPITAL MANAGEMENT, L.P. 0.26% of their portfolio | 2.3m $29.7m | New |
| Point72 Asset Management, L.P. 0.02% of their portfolio | 1.2m $14.9m | New |
| Opaleye Management Inc. 1.07% of their portfolio | 931.0k $11.9m | Reduced -325.2k |
| Logos Global Management LP 0.44% of their portfolio | 800.0k $10.2m | New |
| SummitTX Capital, L.P. 0.25% of their portfolio | 733.8k $9.3m | New |
| VANGUARD CAPITAL MANAGEMENT LLC 0.00% of their portfolio | 518.8k $6.6m | Added +212.4k |
| Ikarian Capital, LLC 0.90% of their portfolio | 430.0k $5.5m | New |
| Woodline Partners LP 0.01% of their portfolio | 286.2k $3.6m | New |
| AMERICAN CENTURY COMPANIES INC 0.00% of their portfolio | 272.8k $3.5m | Added +254.0k |
| Sanofi 0.58% of their portfolio | 244.1k $3.1m | Unchanged |
| ACADIAN ASSET MANAGEMENT LLC 0.00% of their portfolio | 218.2k $2.8m | Added +45.6k |
| ACORN CAPITAL ADVISORS, LLC 0.75% of their portfolio | 216.2k $2.8m | Reduced -98.9k |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 179.6k $2.3m | Reduced -27.3k |
| JANE STREET GROUP, LLC 0.00% of their portfolio | 162.7k $2.1m | Added +97.1k |
| MONIMUS CAPITAL MANAGEMENT, LP 0.43% of their portfolio | 132.0k $1.7m | Reduced -2.3k |
| BOOTHBAY FUND MANAGEMENT, LLC 0.03% of their portfolio | 130.4k $1.7m | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 122.7k $1.6m | Added +4.5k |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 120.7k $1.5m | Added +105.2k |
| BlackRock, Inc. 0.00% of their portfolio | 118.5k $1.5m | Added +32.4k |
| MARSHALL WACE, LLP 0.00% of their portfolio | 67.0k $854.2k | Added +14.6k |
| VANGUARD FIDUCIARY TRUST CO 0.00% of their portfolio | 66.2k $843.6k | Added +16.2k |
| Carlyle Group Inc. 0.01% of their portfolio | 60.4k $769.0k | Reduced -1.0m |
| STATE STREET CORP 0.00% of their portfolio | 52.2k $665.2k | Added +10.7k |
| TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio | 49.6k $631.7k | Added +7.2k |
| Quadrature Capital Ltd 0.00% of their portfolio | 36.4k $463.7k | New |
| Cambridge Investment Research Advisors, Inc. 0.00% of their portfolio | 36.2k $460.0k | Added +1.1k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.01% of their portfolio | 34.6k $441.0k | Added +22.0k |
| DAFNA Capital Management LLC 0.08% of their portfolio | 32.9k $419.1k | New |
| Knott David M Jr 0.20% of their portfolio | 30.4k $387.4k | New |
| Affinity Asset Advisors, LLC 0.02% of their portfolio | 27.8k $353.9k | Unchanged |
| Squarepoint Ops LLC 0.00% of their portfolio | 23.8k $303.1k | New |
| NORTHERN TRUST CORP 0.00% of their portfolio | 23.6k $301.1k | Reduced -1.4k |
| DIMENSIONAL FUND ADVISORS LP 0.00% of their portfolio | 23.6k $300.5k | New |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio | 23.3k $297.4k | New |
| MANGROVE PARTNERS IM, LLC 0.02% of their portfolio | 22.1k $282.2k | New |
| LPL Financial LLC 0.00% of their portfolio | 18.2k $231.5k | New |
| HRT FINANCIAL LP 0.00% of their portfolio | 15.9k $203.0k | New |
| UBS Group AG 0.00% of their portfolio | 15.0k $191.2k | Added +14.7k |
| Balyasny Asset Management L.P. 0.00% of their portfolio | 12.3k $157.2k | New |
| ExodusPoint Capital Management, LP 0.00% of their portfolio | 11.3k $144.4k | New |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 10.9k $139.2k | New |
| XTX Topco Ltd 0.00% of their portfolio | 10.9k $138.5k | New |
| MORGAN STANLEY 0.00% of their portfolio | 6.5k $82.3k | Reduced -3.1k |
| Vanguard Global Advisers, LLC 0.00% of their portfolio | 4.8k $61.5k | Added +2.9k |
| FMR LLC 0.00% of their portfolio | 3.4k $43.2k | Reduced -12 |
| CITIGROUP INC 0.00% of their portfolio | 2.9k $36.8k | New |
| Private Wealth Asset Management, LLC 0.00% of their portfolio | 1.7k $21.7k | New |
| Arax Advisory Partners 0.00% of their portfolio | 1.1k $14.2k | Reduced -37 |
| FEDERATED HERMES, INC. 0.00% of their portfolio | 1.1k $13.4k | Reduced -1.2k |
| Rockefeller Capital Management L.P. 0.00% of their portfolio | 577 $7.4k | Unchanged |
| JONES FINANCIAL COMPANIES LLLP 0.00% of their portfolio | 500 $6.6k | Unchanged |
| Russell Investments Group, Ltd. 0.00% of their portfolio | 454 $5.8k | Unchanged |
| BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio | 303 $3.9k | Unchanged |
| EverSource Wealth Advisors, LLC 0.00% of their portfolio | 240 $3.1k | Reduced -4.4k |
| NISA INVESTMENT ADVISORS, LLC 0.00% of their portfolio | 166 $2.1k | Unchanged |
| Truvestments Capital LLC 0.00% of their portfolio | 162 $2.1k | New |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 124 $1.6k | Unchanged |
| Allworth Financial LP 0.00% of their portfolio | 108 $1.4k | Added +10 |
| SBI Securities Co., Ltd. 0.00% of their portfolio | 94 $1.2k | Reduced -10 |
| Federation des caisses Desjardins du Quebec 0.00% of their portfolio | 70 $888 | Unchanged |
| Clearstead Advisors, LLC 0.00% of their portfolio | 67 $854 | New |
| Caitong International Asset Management Co., Ltd 0.00% of their portfolio | 45 $573 | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 43 $0 | Reduced -2.7k |
| GROUP ONE TRADING LLC 0.00% of their portfolio | 34 $433 | Unchanged |
| HARBOUR INVESTMENTS, INC. 0.00% of their portfolio | 11 $140 | Unchanged |
| AdvisorNet Financial, Inc 0.00% of their portfolio | 2 $25 | Unchanged |
| DANSKE BANK A/S 0.00% of their portfolio | 1 $13 | Unchanged |